Medicilon’s IND Application Platform

Medicilon’s IND application service platform has an in-depth understanding of the regulatory and policy environment of China and the United States and its technical requirements for chemical drugs. It can provide domestic customers with CFDA IND declaration and USFDA IND/ANDA declaration services; it can provide foreign customers with CFDA IND /ANDA declaration service.

The service targets of Medicilon’s IND application platform include not only clients who do a complete set of preclinical research on Medicilon, but also pharmaceutical industry counterparts who require separate registration and declaration. The details are as follows:

Medicilon IND Application Service:

◇ Preparation and submission of CFDA IND documents for domestic customers;

◇ Submission of USFDA IND/ANDA documents as an agent for domestic customers;

◇ Submission of CFDA IND/ANDA documents as an agent for foreign clients;

◇ Provide project management services (limited to clients who provide preclinical research services by Medicilon);

◇ Review, sort out and technical evaluation of the IND/ANDA application documents provided by the customer; and then complete the compilation, review, editing and finalization.

Before submitting the application materials, Medicilon’s registration department will organize an internal technical communication meeting to analyze the application items in detail; after the application materials are submitted, there will be a senior application leader who will continue to communicate with the regulatory agency and follow up the application progress in real time until the application is submitted. Done successfully. In addition, according to the analysis of domestic drug declaration data in recent years, the country’s policy of encouraging innovation has clearly appeared in drug declaration, so it is foreseeable that innovative drugs have a good development momentum in China.

Projects independently declared by Medicilon to complete the entire set of preclinical studies:

◇ 3 IND packages are accepted by USFDA;

◇ 3 IND packages are accepted by TGA;

◇ 15 IND packages have been approved by CFDA;

◇ 10 IND packages have been submitted to CFDA

The complete set of pre-clinical research and declared public projects independently completed by Medicilon:

◇ FZ016, Class 1 chemical drug, plans to apply for CFDA and USFDA IND, has obtained CFDA clinical approval in August 2016, and will apply for USFDA soon

◇ X842, a chemical drug category 1, plans to apply for CFDA, EMEA and USFDA IND. It has submitted EMEA CTA in November 2016 and CFDA IND in January 2017. It will apply for USFDA soon.

Note: The complete set of pre-clinical research includes: API production process and quality research, preparation process and quality research, efficacy, pharmacokinetics and safety evaluation

In order to avoid registration risks, Medicilon’s application service platform can customize practical registration strategies for customers, ensure timely and accurate submission of application materials, and track the review progress in time to help customers quickly complete the registration review process.

Advantages of Medicilon IND application service:

◇ Have a professional IND, ANDA research team, which can provide one-stop research, full project management and reporting services;

◇ Possess a wealth of CFDA, USFDA review expert resources, and can provide targeted technology, regulations, and reporting strategy suggestions.

The management team of Medicilon IND service platform is composed of senior experts led by vice presidents of various departments. It wholeheartedly provides one-stop services for pharmaceutical research, non-clinical research and clinical application for Chinese and American customers.

Contact Us:

Email : marketing@medicilon.com

Tel : +44 1223 981 792（Europe） +86 021 58591500

Website: https://www.medicilon.com

Related Articles:

Medicilon’s IND Filing-innovative drug research and development

IND Enabling Studies FDA

Medicilon successfully held CFDA IND seminar in Seoul, South Korea

Medicilon sponsored the seminar on new drug preclinical research and IND application strategy

What is preclinical testing?

In the process of preclinical testing of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a preclinical research phase followed, before which, as described above, the potential toxicity of the compou

阅读全文

Inventory of the three major in vitro pharmacokinetic research methods

The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d

阅读全文

Enzyme Activity Assay Service

Enzymatic assay Lance Assay Alphascreen Assay Z’-LYTE Assay Adapta Assay Kinase-Glo Assay ADP-Glo Assay Ligand Binding Assay ELISA Assay HTRF Assay Enzyme activity assays are laboratory methods for measuring enzymatic activity. They are vital for the study of enzyme kinetics and enzyme inhibition. Enzyme units : Amounts of enzymes can either be expressed as molar amounts, as with any other chemical, or measured in terms of activity, in enzyme units. Medicilon provides various enzyme activity assays for kinases , phosphatases, proteinases, deacetylase, peptidase, esterase, and other enzymes. Our line of well-characterized immunoassays and biochemical kits ensures accurate and reproducible results. Enzyme is a large category of bio-molecules that catalyze various biological processes including metabolic processes, cellular signaling and regulation, cell division and apoptosis. Enzymatic reactions convert substrate molecules into chemically modified molecules products with high sp

阅读全文

Shanghai Medicilon Inc.

搜索此博客